HEATHER LONG: Open Payments
NPI 1447983051 · BRADENTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$775 in 16 payments from 6 companies in 2025. Trend: 2023 $112 · 2024 $201 · 2025 $775
Food & beverage: $719Education: $56
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 7 | $255 |
| Alnylam Pharmaceuticals Inc. | 1 | $146 |
| Axsome Therapeutics, Inc. | 1 | $124 |
| Regeneron Healthcare Solutions, Inc. | 4 | $123 |
| Lundbeck LLC | 1 | $97 |
| GlaxoSmithKline, LLC. | 2 | $29 |
Products named: DUPIXENT, AMVUTTRA, Auvelity, REXULTI, NUCALA.
Industry payments across FL — which companies pay providers there.
